Name: | Calista Therapeutics, Inc. |
Jurisdiction: | Rhode Island |
Entity type: | Foreign Corporation |
Status: | Activ |
Date of Organization in Rhode Island: | 02 May 2014 (11 years ago) |
Identification Number: | 000929141 |
ZIP code: | 02865 |
County: | Providence County |
Place of Formation: | DELAWARE |
Principal Address: | 32 RIVERSIDE DRIVE, LINCOLN, RI, 02865, USA |
Purpose: | BIOTECHNOLOGY |
NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
ANDREW PETER MALLON | Agent | 32 RIVERSIDE DRIVE, LINCOLN, RI, 02865, USA |
Name | Role | Address |
---|---|---|
ANDREW P. MALLON | PRESIDENT | 32 RIVERSIDE DRIVE LINCOLN, RI 02865 USA |
Number | Name | File Date |
---|---|---|
202448744430 | Annual Report | 2024-03-17 |
202327119010 | Annual Report | 2023-02-01 |
202220877620 | Annual Report | 2022-07-08 |
202220153670 | Revocation Notice For Failure to File An Annual Report | 2022-06-27 |
202187601870 | Annual Report | 2021-01-22 |
202032914610 | Annual Report | 2020-01-23 |
201986175700 | Annual Report | 2019-02-07 |
201877494750 | Annual Report | 2018-09-15 |
201875612660 | Revocation Notice For Failure to File An Annual Report | 2018-08-24 |
201750226210 | Annual Report | 2017-09-21 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PO | AWARD | INL12PX01434 | 2012-08-24 | 2012-11-22 | 2012-11-22 | |||||||||||||||||||||
|
Title | PALEOINDIAN EMER DATA RECOVERY FROM LS-1 |
NAICS Code | 541620: ENVIRONMENTAL CONSULTING SERVICES |
Product and Service Codes | B509: SPECIAL STUDIES/ANALYSIS- ENDANGERED SPECIES: PLANT/ANIMAL |
Recipient Details
Recipient | CALISTA THERAPEUTICS INC |
UEI | E61VUUWBMTB7 |
Legacy DUNS | 078513201 |
Recipient Address | 1 DAVOL SQ STE 203, PROVIDENCE, 029034755, UNITED STATES |
Date of last update: 19 Oct 2024
Sources: Rhode Island Department of State